Aubrey De Grey: longevity escape velocity, longevity, mouse rejuvenation, Altos Labs, Yamanaka factor
Aubrey De Grey talks about the potential and progress of anti-aging therapies, as well as the four therapies which will be tested during a mouse rejuvenation study. He shares his views on working with individuals and organizations in the field. He also discusses the importance of structure and integrating AI in his work. Aubrey de Grey talks about the potential of Yamanaka factors for organ rejuvenation and the role transcription factors play in the creation of induced pluripotent cells. He offers advice to those who are interested in this field, and shares his thoughts on time management and productivity. Aubrey De Grey talks about the possibility of reversing aging’s pathology to address mechanical problems and mentions the promising research being done by MAIA Biotechnology. He expresses optimism that \”longevity-escape velocity\” could be achieved within the next fifteen years.
Youtube:
Aubrey De Grey links.
https://twitter.com/aubreydegrey?ref_src=twsrc%5Egoogle%7Ctw…r%5Eauthor.
https://www.levf.org/
https://www.linkedin.com/in/aubrey-de-grey-24260b/
PODCAST INFORMATION:
The Learning With Lowell series is for everyday mammals. This show will teach us about leadership, science and how people are changing the world. It is our goal to dig deep into the lives of people that we would not normally hear. Lowell Thompson, the host of the show, is a serial problem-solver, entrepreneur, and lifelong autodidact.
LINKS
Youtube: https://www.youtube.com/channel/UCzri06unR-lMXbl6sqWP_-Q
Youtube clips: https://www.youtube.com/channel/UC-B5x371AzTGgK-_q3U_KfA
Linkedin: https://www.linkedin.com/in/lowell-thompson-2227b074
Twitter: https://twitter.com/LWThompson5
Website: https://www.learningwithlowell.com/
Podcast email: [email protected].
Timestamps.
00:00 Start.
Mark Hamaleinen writes in the question of why we still have no therapies based on ideas published in his breakthrough paper 20 years ago.
04:30 update on escape velocity. 50% in 15 Years
08:30 Experiments with mice
Continued research on mice and the Yamanaka Factor.
14:30 Lev Foundation research explained and expanded.
16:30 The Lev Foundation thesis in comparison with others
The innovation field for longevity is dominated by hardships.
23:45 Open source, non profits, lev foundation.
26:00 Ideas from other organizations (i.e. Ideas from previous organizations (i.e.
27:15 Ichor Therapeutics and the partnership process with LEV
29:30 Next generation mentorship.
30:30 Summer internship program.
32:45 Bullish on longevity.
AI and longevity
35:55 Any fundamental treatment that only the wealthy can afford.
38:30 Longevity Surgery Therapies
Advice for people.
40:30 Bottlenecks in longevity
42:00 Books!
Learn to stay on the cutting edge.
44:15 Current fascination and curiosity.
46:45 What does happiness mean to him? And how can he maximize it?
How he maintains his health over the years and what he does to stay healthy.
How much does he need to pay for the space and him?
What is stopping him from getting Jeff Bezos or other high-profile people to donate or invest?
51:55 Thoughts about altos and calico labs.
56:35 Up and coming people who inspire him (crypto-people, Michael Levin)
Find up-and-coming people to work for and with (advice).
60:30 What people get wrong about longevity and what they ask him.
Aubrey Newsletter and Updates (News Suggestions)
He asks a question that he doesn’t know the answer to.
1:04:15 How to maximize your day and stay productive.
1:05.15 Thoughts about MAIA Biotechnology and telomerase.
Final thoughts about the lev foundation.
#longevity #aubreydegrey #LEVF
Source:
